Literature DB >> 16337868

Duplication of the Ph-chromosome as a possible mechanism of resistance to imatinib mesylate in patients with chronic myelogenous leukemia.

A Ossard-Receveur, A Bernheim, B Clausse, G Danglot, D Fauvet, B Leon, F Lozach, D Bories, C Brouzes, J H Bourhis, A G Turhan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16337868     DOI： 10.1016/j.cancergencyto.2005.05.004

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


× No keyword cloud information.
  3 in total

1.  Hyperdiploidy associated with T315I mutation in BCR-ABL kinase domain in an accelerated phase-chronic myeloid leukemia case.

Authors:  Walid Al-Achkar; Faten Moassass; Adnan Ikhtiar; Thomas Liehr; Moneeb Abdullah Kassem Othman; Abdulsamad Wafa
Journal:  Mol Cytogenet       Date:  2014-11-29       Impact factor: 2.009

2.  In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib.

Authors:  Sara Redaelli; Pietro Perini; Monica Ceccon; Rocco Piazza; Roberta Rigolio; Mario Mauri; Frank Boschelli; Athina Giannoudis; Carlo Gambacorti-Passerini
Journal:  J Hematol Oncol       Date:  2015-07-07       Impact factor: 17.388

3.  RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.

Authors:  Tatsuya Masuda; Shintaro Maeda; Sae Shimada; Naoya Sakuramoto; Ken Morita; Asami Koyama; Kensho Suzuki; Yoshihide Mitsuda; Hidemasa Matsuo; Hirohito Kubota; Itaru Kato; Kuniaki Tanaka; Junko Takita; Masahiro Hirata; Tatsuki R Kataoka; Tatsutoshi Nakahata; Souichi Adachi; Hideyo Hirai; Shuichi Mizuta; Kazuhito Naka; Yoichi Imai; Shinya Kimura; Hiroshi Sugiyama; Yasuhiko Kamikubo
Journal:  Cancer Sci       Date:  2021-12-28       Impact factor: 6.716
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.